文献速递神经MR

扩散峰度成像直方图参数预测弥漫性胶质瘤整合分子亚型生存的观察性队列研究

Diffusion kurtosis imaging histogram parameter metrics predicting survival in integrated molecular subtypes of diffuse glioma: An observational cohort study.
PubMed 文献 · Eur J Radiol · 2019-01-15

该研究回顾性纳入77例初治弥漫性胶质瘤患者,评估术前DKI直方图参数(平均峰度MK和平均 diffusivity MD)在2016年WHO中枢神经系统肿瘤整合分类各组中的预后预测价值。结果显示年龄、切除状态、WHO分级和整合分子分型与总生存和无进展生存显著相关;较低MK和较高MD患者生存更好(p=0.009)。结论认为患者年龄和DKI的MK是术前预测总生存和无进展生存的相关因素,在ATRX保留的胶质瘤中似乎具有预测价值。

要点

  • 较低MK和较高MD的胶质瘤患者总生存和无进展生存显著更好(p=0.009)。
  • 患者年龄、切除状态、WHO分级和整合分子分型与生存显著相关。
  • MK和年龄是术前预测总生存和无进展生存的相关因素。

核心结论

  • 患者年龄和DKI的MK是术前预测总生存和无进展生存的相关因素;在分子亚组中,这些参数似乎在ATRX保留的胶质瘤中具有预测价值,而ATRX保留是IDH野生型胶质瘤的特征。

研究设计与样本

  • 回顾性观察性队列研究,纳入2013年8月至2017年10月间77例组织病理学确诊的初治胶质瘤患者,术前行DKI检查,提取平均峰度(MK)和平均扩散率(MD)直方图参数,并收集IDH、ATRX、染色体1p/19q杂合性缺失等分子数据,采用ROC分析确定最佳截断值,Kaplan-Meier法进行单因素生存分析,对单因素显著结果行多因素Cox比例风险模型分析。

诊断标准与关键数值

  • 采用ROC分析确定MK和MD等指标的最佳截断值;生存分析显示较低MK和较高MD患者总生存和无进展生存显著更好(p=0.009);染色体1p/19q无杂合性缺失的胶质瘤生存显著更好(p<0.0001);ATRX表达保留者生存显著更好(p=0.008)。

临床应用与阅片要点

  • 术前DKI直方图参数MK和MD可用于辅助预测弥漫性胶质瘤患者的总生存和无进展生存,尤其应关注ATRX表达保留的IDH野生型胶质瘤亚组。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of the study was to assess the predictive value of preoperatively assessed diffusion kurtosis imaging (DKI) metrics as prognostic factors in the 2016 World Health Organization Classification of Tumors of the Central Nervous System integrated glioma groups.

MATERIAL AND METHODS: Seventy-seven patients with histopathologically confirmed treatment-naïve glioma were retrospectively assessed between 08/2013 and 10/2017 using mean kurtosis (MK) and mean diffusivity (MD) histogram parameters from DKI, overall and progression-free survival, and relevant prognostic molecular data (isocitrate dehydrogenase, [IDH]; alpha-thalassemia/mental retardation syndrome X-linked, [ATRX]; chromosome 1p/19q loss of heterozygosity). Receiver operating characteristic (ROC) analysis was performed on metric variables to determine the optimal cutoff-values. The Kaplan-Meier method was used to assess univariate survival data. A multivariate Cox proportional hazards model was performed on significant results from the univariate analysis.

RESULTS: There were significant differences in overall and progression-free survival between patient age (p = 0.001), resection statuses (p = 0.002), WHO glioma grades (p < 0.0001), and integrated molecular profiles (p < 0.0001). Survival was significantly better in patients with lower MK and higher MD values globally (p = 0.009), in gliomas without chromosome 1p/19q LOH (p < 0.0001), and those with retained ATRX expression (p = 0.008).

CONCLUSIONS: Patient age and MK from DKI from DKI are relevant factors for preoperatively predicting overall and progression-free survival. Regarding the molecular subgroups, they seem to be predictive in gliomas with ATRX retention, representing a feature of IDH wild-type gliomas.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Hempel JM, Brendle C, Bender B, et al. Diffusion kurtosis imaging histogram parameter metrics predicting survival in integrated molecular subtypes of diffuse glioma: An observational cohort study. Eur J Radiol. 2019. PMID: 30777204. doi:10.1016/j.ejrad.2019.01.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。